BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Aposense Ltd. (Formerly known as NST NeuroSurvival Technologies Ltd.) 

5-7 Odem Street
P.O. Box 7119
Petach-Tikva    49170  Israel
Phone: 972-3-921-57-17 Fax: 972-3-921-57-14


SEARCH JOBS


Industry
Biotechnology

Segment
Biotechnology





 Company News
Aposense Ltd. (Formerly known as NST NeuroSurvival Technologies Ltd.) Cancer Drug Demonstrates 100% Oral Bioavailability in New Study 9/6/2011 9:17:27 AM    More...
Roche (RHHBY) to Use Aposense Ltd. (Formerly known as NST NeuroSurvival Technologies Ltd.) EarliTest(TM) for Imaging of Apoptosis in Oncology Clinical Trials 11/9/2010 9:55:36 AM    More...
Aposense Ltd. (Formerly known as NST NeuroSurvival Technologies Ltd.) Announces Successful Completion of IPO 6/7/2010 7:20:28 AM    More...
Ion Beam Applications (IBA) And Aposense Ltd. (Formerly known as NST NeuroSurvival Technologies Ltd.) Sign Strategic Collaboration to Commercialize Aposense(R) ML-10 for Molecular Imaging of Apoptosis 9/21/2009 11:10:21 AM    More...
Aposense Ltd. (Formerly known as NST NeuroSurvival Technologies Ltd.) Imaging Agent Detects Early Cell Death Induced by Radiation in Patients With Brain Metastases 6/16/2009 11:58:04 AM    More...
Aposense Ltd. (Formerly known as NST NeuroSurvival Technologies Ltd.) ML-10 Technology for Molecular Imaging of Apoptosis to Be Used by GlaxoSmithKline (GSK) in Experimental Oncology Studies 6/8/2009 11:59:03 AM    More...
Aposense Ltd. (Formerly known as NST NeuroSurvival Technologies Ltd.) Apoptosis Imaging Program for Cancer Therapy Monitoring Initiates a Phase II Multi-Center Study at Memorial Sloan-Kettering Cancer Center 12/15/2008 9:14:43 AM    More...
Aposense Ltd. (Formerly known as NST NeuroSurvival Technologies Ltd.) Completes $13.3 Million Financing 8/20/2008 6:15:12 AM    More...
NST NeuroSurvival Technologies Ltd. Release: APOSENSE(R) [18F]-ML-10 for Molecular Imaging of Apoptosis to Proceed to Phase I/II Trials 7/23/2008 10:44:28 AM    More...
Sigma-Aldrich Corporation (SIAL) Licenses From NeuroSurvival Technologies 2/26/2008 11:35:05 AM    More...

//-->